How is hematuria from prostatic origin?

BPH represents the most common cause of GH in men older than 60 years. • 5α-Reductase inhibitors may be used for BPH-related GH. • Androgen deprivation may be effective for patients with locally advanced prostate cancer with GH. • Angioembolization and/or urinary diversion represent salvage options for management for patients with refractory hematuria, pending clinical status.